Showing 20 of 75 recruiting trials for “squamous-cell-carcinoma-of-the-larynx”
RecruitingNCT06321939 ↗
Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
Doxepin Solution for Alleviation of Stubborn Breakthrough Pain Induced by Swallowing in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma
👨⚕️ Jian Guan, MD, Nanfang Hospital, Southern Medical University📍 1 site📅 Started Oct 2023View details ↗
NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma
👨⚕️ Ying Wang, Ph.D, M.D., Chongqing University Cancer Hospital📍 1 site📅 Started Oct 2023View details ↗
Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy
Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
👨⚕️ Xiaozhong Chen, Department of Radiation Oncology, Zhejiang Cancer Hospital📍 1 site📅 Started Sep 2023View details ↗
Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
Metastatic Nasopharyngeal Carcinoma
Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC
Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma
RecruitingNCT05884983 ↗
Screening Effect of Dual-energy CT Combined With Nasopharyngeal Endoscopy for Screening Nasopharyngeal Carcinoma
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
RecruitingNCT05858385 ↗
Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
🏥 Affiliated Cancer Hospital & Institute of Guangzhou Medical University📍 1 site📅 Started Sep 2022View details ↗
SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
Optimization of Cervical Nodal CTV for Early and Medium Stage NPC
RecruitingNCT05707819 ↗
Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
👨⚕️ Xiao-Dong Zhu, Doctor, Cancer Hospital of Guangxi Medical University📍 1 site📅 Started Jul 2022View details ↗
Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal Carcinoma
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma
Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →